← Zuruck zu CVEs
CVE-2012-2717
N/ABeschreibung
Multiple cross-site scripting (XSS) vulnerabilities in the Mobile Tools module 6.x-2.x before 6.x-2.3 for Drupal allow remote attackers to inject arbitrary web script or HTML via the (1) Mobile URL field or (2) Desktop URL field to the General configuration page, or the (3) message to the Mobile Tools block message options.
CVE Details
CVSS v3.1 BewertungN/A
Veroffentlicht6/27/2012
Zuletzt geandert4/29/2026
Quellenvd
Honeypot-Sichtungen0
Betroffene Produkte
drupal:drupalmathew_winstone:mobile_tools
Schwachen (CWE)
CWE-79
Referenzen
http://drupal.org/node/1169008(secalert@redhat.com)
http://drupal.org/node/1608828(secalert@redhat.com)
http://drupalcode.org/project/mobile_tools.git/commitdiff/614b0fc(secalert@redhat.com)
http://osvdb.org/82410(secalert@redhat.com)
http://secunia.com/advisories/49318(secalert@redhat.com)
http://www.madirish.net/content/drupal-mobile-tools-6x-23-xss(secalert@redhat.com)
http://www.openwall.com/lists/oss-security/2012/06/14/3(secalert@redhat.com)
http://www.securityfocus.com/bid/53734(secalert@redhat.com)
https://exchange.xforce.ibmcloud.com/vulnerabilities/76002(secalert@redhat.com)
http://drupal.org/node/1169008(af854a3a-2127-422b-91ae-364da2661108)
http://drupal.org/node/1608828(af854a3a-2127-422b-91ae-364da2661108)
http://drupalcode.org/project/mobile_tools.git/commitdiff/614b0fc(af854a3a-2127-422b-91ae-364da2661108)
http://osvdb.org/82410(af854a3a-2127-422b-91ae-364da2661108)
http://secunia.com/advisories/49318(af854a3a-2127-422b-91ae-364da2661108)
http://www.madirish.net/content/drupal-mobile-tools-6x-23-xss(af854a3a-2127-422b-91ae-364da2661108)
http://www.openwall.com/lists/oss-security/2012/06/14/3(af854a3a-2127-422b-91ae-364da2661108)
http://www.securityfocus.com/bid/53734(af854a3a-2127-422b-91ae-364da2661108)
https://exchange.xforce.ibmcloud.com/vulnerabilities/76002(af854a3a-2127-422b-91ae-364da2661108)
IOC Korrelationen
Keine Korrelationen erfasst
This product uses data from the NVD API but is not endorsed or certified by the NVD.